Showing results (1181-1190 of 1,211) with videos related to

Sort By:
Pageof 122
The New England Journal of Medicine|August 30, 2024
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, John L Berk, Julian D Gillmore, et al.
Journal of the American College of Cardiology|October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
The New England Journal of Medicine|September 1, 2025
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older AdultsMats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|March 20, 2023
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection FractionSheldon E Litwin, Jan Komtebedde, Mo Hu, et al.
European Journal of Preventive Cardiology|June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV TrialCaroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
Circulation|March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart FailureBarry A Borlaug, John Blair, Martin W Bergmann, et al.
JAMA|March 29, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without DiabetesMark C Petrie, Subodh Verma, Kieran F Docherty, et al.
The New England Journal of Medicine|September 20, 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J V McMurray, Scott D Solomon, Silvio E Inzucchi, et al.
Pageof 122